Zobrazeno 1 - 10
of 193
pro vyhledávání: '"MESH: Lymphoma"'
Autor:
Patrick Schmid, Enos Bernasconi, Ioannis Theodorou, Sophia S. Wang, Pejman Mohammadi, Paul J. McLaren, Huldrych F. Günthard, Matthias Cavassini, Charles S. Rabkin, Matthias Hoffmann, Christian Hammer, Shehnaz K. Hussain, Jacques Fellay, Andri Rauch, Cécile Goujard, Laurence Meyer, Jonathan Niay, Caroline Besson, Nava Ehsan, Tiphaine Oudot-Mellakh, Dominique Costagliola, Manuel Battegay, Christian W. Thorball, Federico Santoni
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2021, 106 (8), pp.2233-2241. ⟨10.3324/haematol.2020.247023⟩
Haematologica, vol. 106, no. 8, pp. 2233-2241
Haematologica, Ferrata Storti Foundation, 2021, 106 (8), pp.2233-2241. ⟨10.3324/haematol.2020.247023⟩
Haematologica, vol. 106, no. 8, pp. 2233-2241
International audience; Human immunodeficiency virus (HIV) infection is associated with an increased risk of non-Hodgkin lymphoma (NHL). Even in the era of suppressive antiretroviral treatment, HIV-infected individuals remain at higher risk of develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e896ca36e59f52f7ebdd6a72f38073b
https://doi.org/10.3324/haematol.2020.247023
https://doi.org/10.3324/haematol.2020.247023
Autor:
Roberta Di Blasi, Laure Philippe, Thomas Hueso, Catherine Thieblemont, Karine Lacombe, Bénédicte Deau Fischer, Serge Bologna, Caroline Besson, Guillemette Fouquet, Sylvain Choquet, Milena Kohn, Rémy Duléry, Carole Soussain, Bernard Drenou, Pierre Feugier, Etienne Daguindau, Marc Delord, Nicolas Noel, Adrien Chauchet, Sylvain Lamure, Sandra Malak, Cédric Rossi, Bertrand Joly, Guillaume Cartron, Yassine Taoufik
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
American Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
American Journal of Hematology, Wiley, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
American Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
International audience; Prolonged Covid-19 is an emerging issue for patients with lymphoma or immune deficiency. We aimed to examine prolonged length of in-hospital stay (LOS) due to Covid-19 among patients with lymphoma and assess its determinants a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c93552a83f08f61d53fc23e10bf133
https://doi.org/10.1002/ajh.26209
https://doi.org/10.1002/ajh.26209
Autor:
Agnes Nagy, Rene-Olivier Casasnovas, Sameer Bakhshi, Sharon Shacham, Juan-Manuel Sancho, Ronit Gurion, Josée M. Zijlstra, Jatin P. Shah, Miklos Egyed, Brian T. Hill, Krzysztof Warzocha, Gabriel Tremblay, Michael W. Schuster, Fritz Offner, Reda Bouabdallah, Dimitrios Tomaras, Paolo Caimi, Andre Goy, Priyanka Samal, Catherine Thieblemont, Joost S.P. Vermaat, Matthew Ku, Ulrich Jäger, John Kuruvilla, Nagesh Kalakonda, George A Follows, Eric Van Den Neste, Miguel Ángel Canales Albendea, Michael Kauffman, Nada Hamad, Fatima De la Cruz, Patrick Daniele, Marie Maerevoet, Theodoros Vasilakopoulos, Federica Cavallo, Sylvain Choquet
Publikováno v:
Future Oncology
Future Oncology, Future Medicine, 2021, 17 (11), pp.1295-1310. ⟨10.2217/fon-2020-0946⟩
Future Oncology, 17(11), 1295-1310. FUTURE MEDICINE LTD
FUTURE ONCOLOGY
Future oncology, Vol. 17, no.11, p. 1295-1310 (2021)
Future Oncology, Future Medicine, 2021, 17 (11), pp.1295-1310. ⟨10.2217/fon-2020-0946⟩
Future Oncology, 17(11), 1295-1310. FUTURE MEDICINE LTD
FUTURE ONCOLOGY
Future oncology, Vol. 17, no.11, p. 1295-1310 (2021)
Aim: Evaluate health-related quality of life (HRQoL) and health utility impact of single-agent selinexor in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma. Patients & methods: Functional Assessment of Cancer Therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6489da8e0ec446342a61908102b6dd3
https://doi.org/10.2217/fon-2020-0946
https://doi.org/10.2217/fon-2020-0946
Autor:
Michael Wang, Javier Munoz, Andre Goy, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, Houston Holmes, Samantha Jaglowski, Ian W. Flinn, Peter A. McSweeney, David B. Miklos, John M. Pagel, Marie José Kersten, Krimo Bouabdallah, Rashmi Khanal, Max S. Topp, Roch Houot, Amer Beitinjaneh, Weimin Peng, Xiang Fang, Rhine R. Shen, Rubina Siddiqi, Ioana Kloos, Patrick M. Reagan
Publikováno v:
Journal of Clinical Oncology, 94:02370. American Society of Clinical Oncology
Journal of clinical oncology, 94:02370. American Society of Clinical Oncology
Journal of Clinical Oncology
Journal of Clinical Oncology, 2023, 41 (3), pp.555-567. ⟨10.1200/JCO.21.02370⟩
Wang, M, Munoz, J, Goy, A, Locke, F L, Jacobson, C A, Hill, B T, Timmerman, J M, Holmes, H, Jaglowski, S, Flinn, I W, Mcsweeney, P A, Miklos, D B, Pagel, J M, Kersten, M J, Bouabdallah, K, Khanal, R, Topp, M S, Houot, R, Beitinjaneh, A, Peng, W, Fang, X, Shen, R R, Siddiqi, R, Kloos, I & Reagan, P M 2022, ' Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study ', Journal of Clinical Oncology, vol. 94, 02370 . https://doi.org/10.1200/JCO.21.02370
Journal of clinical oncology, 94:02370. American Society of Clinical Oncology
Journal of Clinical Oncology
Journal of Clinical Oncology, 2023, 41 (3), pp.555-567. ⟨10.1200/JCO.21.02370⟩
Wang, M, Munoz, J, Goy, A, Locke, F L, Jacobson, C A, Hill, B T, Timmerman, J M, Holmes, H, Jaglowski, S, Flinn, I W, Mcsweeney, P A, Miklos, D B, Pagel, J M, Kersten, M J, Bouabdallah, K, Khanal, R, Topp, M S, Houot, R, Beitinjaneh, A, Peng, W, Fang, X, Shen, R R, Siddiqi, R, Kloos, I & Reagan, P M 2022, ' Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study ', Journal of Clinical Oncology, vol. 94, 02370 . https://doi.org/10.1200/JCO.21.02370
PURPOSE Brexucabtagene autoleucel (KTE-X19) autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is approved for the treatment of relapsed/refractory mantle cell lymphoma (MCL). Outcomes after a 3-year follow-up in the pivotal ZUMA-2 s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47eb8b07d9f89522a14b8f20081cb6f6
https://research.vumc.nl/en/publications/4b65d325-cfe4-4902-889d-10f9ca14f692
https://research.vumc.nl/en/publications/4b65d325-cfe4-4902-889d-10f9ca14f692
Autor:
Leticia Quintanilla-Martinez, Inga Müller, Dominik Nann, Itziar Salaverria, Julia Salmeron-Villalobos, Falko Fend, Barbara Mankel, Blanca Gonzalez-Farre, Dolors Colomer, Sven Mattern, Elaine S. Jaffe, Stefan Dojcinov, Irina Bonzheim, Christiane Copie-Bergman, Lorenzo Leoncini, Olga Balagué, Joan Enric Ramis-Zaldivar, Caoimhe Egan, Vanessa Szablewski, Elias Campo, Carmen Lome-Maldonado, Andreas Chott, Guillem Clot, Janine Schmidt, Franziska Otto
Publikováno v:
Blood Advances
Blood Advances, The American Society of Hematology, 2020, 4 (22), pp.5652-5665. ⟨10.1182/bloodadvances.2020002944⟩
Blood Adv
Blood Advances, The American Society of Hematology, 2020, 4 (22), pp.5652-5665. ⟨10.1182/bloodadvances.2020002944⟩
Blood Adv
Fifty-five cases of t(14;18)− follicular lymphoma (FL) were genetically characterized by targeted sequencing and copy number (CN) arrays. t(14;18)− FL predominated in women (M/F 1:2); patients often presented during early clinical stages (71%), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a43c816345e6650727997dfe41da2f
https://hal.umontpellier.fr/hal-03228849
https://hal.umontpellier.fr/hal-03228849
Autor:
Papouin, Barbara
Publikováno v:
Médecine humaine et pathologie. 2019
Immunosuppressive enzymes are involved in the immune escape of cancers, and can be therapeutic targets. Their expression have never been studied in cutaneous lymphoma (CL). In a retrospective, single-center and descriptive study, we analysed using im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::b811d0d2e82d8fac1d1a0af5d4d5be06
https://dumas.ccsd.cnrs.fr/dumas-02996785
https://dumas.ccsd.cnrs.fr/dumas-02996785
Autor:
José Adélaïde, Max Chaffanet, Nadine Carbuccia, Anne Murati, Reda Bouabdallah, Lénaïg Mescam, Morgan Avenin, Daniel Birnbaum, Luc Xerri, Diane Coso, Sebastien Taix, François Bertucci, Séverine Garnier, N. Bonnet, Arnaud Guille
Publikováno v:
Histopathology
Histopathology, Wiley, 2019, 74 (4), pp.654-662. ⟨10.1111/his.13783⟩
Histopathology, 2019, 74 (4), pp.654-662. ⟨10.1111/his.13783⟩
Histopathology, Wiley, 2019, 74 (4), pp.654-662. ⟨10.1111/his.13783⟩
Histopathology, 2019, 74 (4), pp.654-662. ⟨10.1111/his.13783⟩
AIMS This study sought to clarify the molecular pathways underlying the putative evolution from lymphomatoid papulosis (LyP) to cutaneous anaplastic large-cell lymphoma (c-ALCL) and lymph node invasion (LNI). METHODS AND RESULTS We analysed nine sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6607f95f8c5e4ff5addd880c2464eb02
https://hal.archives-ouvertes.fr/hal-02533424
https://hal.archives-ouvertes.fr/hal-02533424
Autor:
Emmanuel Cornillot, Vanessa Lacheretz-Szablewski, Valérie Costes-Martineau, Valérie Rigau, Valère Cacheux, Melissa Alame, Jacques Colinge
Publikováno v:
Theranostics
Theranostics, 2021, 11 (8), pp.3565-3579. ⟨10.7150/thno.54343⟩
Theranostics, 2021, 11 (8), pp.3565-3579. ⟨10.7150/thno.54343⟩
International audience; Rationale: Primary central nervous system diffuse large B-cell lymphoma (PCNSL) is a rare and aggressive entity that resides in an immune-privileged site. The tumor microenvironment (TME) and the disruption of the immune surve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d0670090a5cfc5cd681bc72f5728cb
https://pubmed.ncbi.nlm.nih.gov/33664848
https://pubmed.ncbi.nlm.nih.gov/33664848
Autor:
Martin J. S. Dyer, Lingling Han, Guillaume Cartron, Siddhartha Mitra, Christopher Fegan, Franck Morschhauser, Simon Rule, Gilles Salles
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (5), pp.1458-1461. ⟨10.1038/s41375-019-0658-7⟩
Leukemia, 2020, 34 (5), pp.1458-1461. ⟨10.1038/s41375-019-0658-7⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (5), pp.1458-1461. ⟨10.1038/s41375-019-0658-7⟩
Leukemia, 2020, 34 (5), pp.1458-1461. ⟨10.1038/s41375-019-0658-7⟩
International audience; Recent therapeutic advances for mantle cell lymphoma (MCL) include inhibitors of Bruton’s tyrosine kinase (BTK), a critical component in the B-cell receptor signaling pathway [1, 2]. Remarkably, approximately two thirds of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067e53defeebda158578df5866c12809
https://hal.umontpellier.fr/hal-03383683
https://hal.umontpellier.fr/hal-03383683
Autor:
Menguy, Sarah, Mansour, Yara, Jullié, Marie-Laure, Augereau, Olivier, Ortonne, Nicolas, Balme, Brigitte, Battistella, Maxime, Lamant, Laurence, Beltzung, Fanny, Szablewski, Vanessa, Gaulard, Philippe, Bagot, Martine, Beylot-Barry, Marie, Vergier, Béatrice
Publikováno v:
Annales de Pathologie
Annales de Pathologie, Elsevier Masson, 2021, 41 (3), pp.290-299. ⟨10.1016/j.annpat.2021.03.015⟩
Annales de Pathologie, Elsevier Masson, 2021, 41 (3), pp.290-299. ⟨10.1016/j.annpat.2021.03.015⟩
International audience; After a first diagnosis proposition, management of cutaneous lymphomas requires a systematic review by an expert pathologist and each case is presented to a multidisciplinary meeting in the setting of the French Study Group of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::da1d4087e7a985d705a802d0a4f9eb6b
https://pubmed.ncbi.nlm.nih.gov/33926757
https://pubmed.ncbi.nlm.nih.gov/33926757